QR kód

Current insights into monitoring of congenital adrenal hyperplasia

The management of 21-hydroxylase deficiency (21OHD), the most common form of congenital adrenal hyperplasia, remains challenging as both over- and undertreatment with hormone replacement therapy are associated with short and long-term complications. Monitoring of treatment efficacy typically combine...

Celý popis

Uloženo v:
Hlavní autoři: Quinty M. Leusink, Elke E. W. Verploegen, Bas P. H. Adriaansen, Xinyi Chin, Nike M. M. L. Stikkelbroeck, Paul N. Span, Fred C. G. J. Sweep, Margo Dona, Antonius E. van Herwaarden, Hedi L. Claahsen-van der Grinten
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2026-02-01
Edice:Frontiers in Endocrinology
Témata:
congenital adrenal hyperplasia (CAH)
21-hydroxylase deficiency (21OHD)
monitoring
biomarkers
reference intervals
On-line přístup:https://www.frontiersin.org/articles/10.3389/fendo.2026.1774145/full
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky